Life Sciences

The year-long battle over National Institutes of Health funding, which caused UMass Chan Medical School to lay off employees in April, reached a new milestone on Tuesday.

CCC was not placed into receivership, no hospital replaced Nashoba Valley Medical Center, and the results of eight other bold predictions for 2025.

As the use of GLP-1s, like Ozempic, has skyrocketed in the U.S., two researchers at UMass Chan Medical School in Worcester have received a $2 million award from the Centers for Disease Control and Prevention to study lifestyle change of those taking the popular drug.

The BOB awards recognize the best business-to-business companies in Central Massachusetts: those dedicated to excellence and delivering exceptional products.

Five Central Massachusetts life sciences companies are splitting $5 million in tax incentives to create 245 jobs in the region.

Nominees were evaluated independently by three volunteer judges, who scored each on their professional achievements, community contributions, and mentorship of young professionals.

The lab, located at 260 Cedar Hill St., will serve as a hub for the company’s research efforts as it works to convert carbon dioxide into degradable, high-performance polymers.

The company says the deal will allow customers to source a comprehensive range of precision tools from a single source, saving time and simplifying the procurement process.

The report comes less than a week after the Supreme Court ruled that the Trump administration can slash nearly $800 million in National Institutes of Health funding.

Lifeward had a second executive join its C-suite transition in two months as the Marlborough-based medical device has selected its new CFO.